US Map / Indiana
State IN

Clinical Trials in Indiana

Indiana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Indiana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 178 actively recruiting studies with Indiana sites out of 178 registered in total. The busiest research areas in Indiana are Heart Failure, Cancer, Prostate Cancer. Leading sponsors running trials in the state include Indiana University, Bristol-Myers Squibb, National Cancer Institute (NCI). By stage, Indiana trials break down as Phase 1 (17), Phase 2 (44), Phase 3 (55), Phase 4 (7).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
178
Recruiting Now
178
← Back to US Map
Top Conditions in Indiana
Heart Failure (5)Cancer (4)Prostate Cancer (3)Stroke (3)Atrial Fibrillation (AF) (2)Recurrent Malignant Solid Neoplasm (2)Triple Negative Breast Cancer (2)Ulcerative Colitis (2)Primary Membranous Nephropathy (2)Large B-cell Lymphoma (2)Non-Small Cell Lung Cancer (2)Obesity (2)

Frequently Asked Questions — Clinical Trials in Indiana

How many clinical trials are currently recruiting in Indiana?
ClinicalMetric currently tracks 178 actively recruiting clinical trials with at least one location in Indiana. The total number of registered studies—including active but not currently enrolling trials—is 178. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Indiana?
Indiana hosts clinical trials across a broad range of medical conditions, including Heart Failure, Cancer, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Indiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Indiana?
To join a clinical trial in Indiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Indiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Indiana

NCT03072927 N/A
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Condition
Lumbar Spinal Stenosis
Enrollment
8,000 pts
Location
United States
Sponsor
Stryker Instruments
View Trial →
NCT06623422 Phase 3
Recruiting
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
680 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07633470 Phase 4
Recruiting
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Careg...
Condition
Alzheimer Disease
Enrollment
150 pts
Location
United States
Sponsor
Alpha Cognition, Inc
View Trial →
NCT06641466 Phase 3
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used f...
Condition
Menstrual Migraine
Enrollment
723 pts
Location
United States, Argentina, Canada
Sponsor
Pfizer
View Trial →
NCT07420530 Phase 2
Recruiting
Respiratory and Real-time Dynamics in Exercise-Induced Paradoxical Vocal Fold Mo...
Condition
Exercise-Induced Vocal Cord Dysfunction
Enrollment
120 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT04088071 N/A
Recruiting
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Condition
Paroxysmal Atrial Fibrillation
Enrollment
20,000 pts
Location
United States, Canada
Sponsor
Heart Rhythm Clinical and Rese
View Trial →
NCT06784999 Phase 4
Recruiting
Sufentanil Infusion vs Intravenous Methadone for Postoperative Analgesia Followi...
Condition
Free Flap Reconstruction
Enrollment
128 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT04994756 N/A
Recruiting
Stroke Thrombectomy and Aneurysm Registry
Condition
Stroke
Enrollment
40,000 pts
Location
United States, Canada, Germany
Sponsor
Medical University of South Ca
View Trial →
NCT06873945 Phase 3
Recruiting
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alop...
Condition
Alopecia Areata
Enrollment
674 pts
Location
United States, Canada, China
Sponsor
Pfizer
View Trial →
NCT07729137 Phase 2
Recruiting
Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial ...
Condition
Corneal Edema
Enrollment
121 pts
Location
United States
Sponsor
Emmecell
View Trial →
NCT06868719 N/A
Recruiting
Ketone Ester And Salt (KEAS) in Older Adults
Condition
Salt; Excess
Enrollment
35 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT06477172 N/A
Recruiting
Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures
Condition
Post Procedural Erythema
Enrollment
500 pts
Location
United States, Canada
Sponsor
Acorn Biolabs Inc.
View Trial →
NCT07553637 Phase 2
Recruiting
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Condition
Treatment-resistant Depression (TRD)
Enrollment
178 pts
Location
United States, United Kingdom
Sponsor
Alto Neuroscience
View Trial →
NCT07232030 N/A
Recruiting
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Fai...
Condition
Heart Failure
Enrollment
2,500 pts
Location
United States
Sponsor
CVRx, Inc.
View Trial →
NCT07733765 Phase 3
Recruiting
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for ...
Condition
Alopecia Areata
Enrollment
336 pts
Location
United States, Canada, China
Sponsor
Pfizer
View Trial →
NCT07100990 Phase 3
Recruiting
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasm...
Condition
Optic Neuritis
Enrollment
382 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT07556341 N/A
Recruiting
Point-of-care Ultrasound Utility in the Free Clinic Setting
Condition
Point of Care Ultrasound (POCUS)
Enrollment
50 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT07559227 N/A
Recruiting
Gut, Immune, and Vascular Health in Metabolically Healthy Obesity
Condition
Metabolically Healthy Obesity
Enrollment
70 pts
Location
United States
Sponsor
Ball State University
View Trial →
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
LEO Pharma
View Trial →
NCT07746388 Phase 2
Recruiting
Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial
Condition
Nsclc
Enrollment
30 pts
Location
United States
Sponsor
University of Maryland, Baltim
View Trial →
NCT07819773 N/A
Recruiting
Device for Treating Generalized Anxiety
Condition
Generalized Anxiety Disorder (GAD)
Enrollment
40 pts
Location
United States
Sponsor
BTL Industries Ltd.
View Trial →
NCT06937086 Phase 3
Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants W...
Condition
Ulcerative Colitis
Enrollment
350 pts
Location
United States, Austria, Belgium
Sponsor
Eli Lilly and Company
View Trial →
NCT06500273 Phase 2
Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Condition
Large B-cell Lymphoma
Enrollment
250 pts
Location
United States, Australia, Canada
Sponsor
Allogene Therapeutics
View Trial →
NCT06128629 Phase 3
Recruiting
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amylo...
Condition
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Enrollment
1,200 pts
Location
United States, Argentina, Australia
Sponsor
Intellia Therapeutics
View Trial →
NCT07729462 Phase 3
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used ...
Condition
Preventive Treatment of Migraine
Enrollment
400 pts
Location
United States, Israel
Sponsor
Pfizer
View Trial →
Page 7 of 8 — 178 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology